Mutations in sphingolipid metabolism genes are associated with ADHD

ABSTRACT: Attention deficit hyperactivity disorder (ADHD) is the most prevalent neurodevelopmental disorder in children, with genetic factors accounting for 75-80% of the phenotypic variance. Recent studies have suggested that ADHD patients might present with atypical central myelination that can pe...

Full description

Autores:
Arcos Burgos, Oscar Mauricio
Palacio Ortiz, Juan David
Lopera Restrepo, Francisco Javier
Acosta, María T.
Martínez, Ariel F.
Vélez Vallbuena, Jorge Iván
Henriquez Henriquez, Marcela
Pineda Salazar, David Antonio
Quiroga, Teresa
Worgall, Tilla S.
Deckelbaum, Richard J.
Mastronardi, Claudio
Molina, Brooke S. G.
Muenke, Maximilian
Tipo de recurso:
Article of investigation
Fecha de publicación:
2020
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/42124
Acceso en línea:
https://hdl.handle.net/10495/42124
Palabra clave:
Attention Deficit Disorder with Hyperactivity
Trastorno por Déficit de Atención con Hiperactividad
Genetic Predisposition to Disease
Predisposición Genética a la Enfermedad
Mutation
Mutación
Polymorphism, Single Nucleotide
Polimorfismo de Nucleótido Simple
Sphingolipids
Esfingolípidos
Sphingomyelin Phosphodiesterase
Esfingomielina Fosfodiesterasa
https://id.nlm.nih.gov/mesh/D001289
https://id.nlm.nih.gov/mesh/D020022
https://id.nlm.nih.gov/mesh/D009154
https://id.nlm.nih.gov/mesh/D020641
https://id.nlm.nih.gov/mesh/D013107
https://id.nlm.nih.gov/mesh/D013108
Rights
openAccess
License
http://creativecommons.org/licenses/by/2.5/co/
Description
Summary:ABSTRACT: Attention deficit hyperactivity disorder (ADHD) is the most prevalent neurodevelopmental disorder in children, with genetic factors accounting for 75-80% of the phenotypic variance. Recent studies have suggested that ADHD patients might present with atypical central myelination that can persist into adulthood. Given the essential role of sphingolipids in myelin formation and maintenance, we explored genetic variation in sphingolipid metabolism genes for association with ADHD risk. Whole-exome genotyping was performed in three independent cohorts from disparate regions of the world, for a total of 1520 genotyped subjects. Cohort 1 (MTA (Multimodal Treatment study of children with ADHD) sample, 371 subjects) was analyzed as the discovery cohort, while cohorts 2 (Paisa sample, 298 subjects) and 3 (US sample, 851 subjects) were used for replication. A set of 58 genes was manually curated based on their roles in sphingolipid metabolism. A targeted exploration for association between ADHD and 137 markers encoding for common and rare potentially functional allelic variants in this set of genes was performed in the screening cohort. Single- and multi-locus additive, dominant and recessive linear mixed-effect models were used. During discovery, we found statistically significant associations between ADHD and variants in eight genes (GALC, CERS6, SMPD1, SMPDL3B, CERS2, FADS3, ELOVL5, and CERK). Successful local replication for associations with variants in GALC, SMPD1, and CERS6 was demonstrated in both replication cohorts. Variants rs35785620, rs143078230, rs398607, and rs1805078, associated with ADHD in the discovery or replication cohorts, correspond to missense mutations with predicted deleterious effects. Expression quantitative trait loci analysis revealed an association between rs398607 and increased GALC expression in the cerebellum.